Effectiveness of supportive care measures to reduce infections in pediatric AML: A report from the Children's Oncology Group

Blood

Volumn 121, Issue 18, 2013, Pages 3573-3577

  Sung, Lillian ^a   Aplenc, Richard ^b   Alonzo, Todd A ^c,d   Gerbing, Robert B ^c   Lehrnbecher, Thomas ^e   Gamis, Alan S ^f  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e GOETHE UNIVERSITY   (Germany)

^f CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; PENICILLIN DERIVATIVE; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILD; CHILDHOOD LEUKEMIA; CLOSTRIDIUM DIFFICILE INFECTION; FEMALE; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE CYCLE TREATMENT; MYCOSIS; PRIORITY JOURNAL; ANTIBIOTIC PROPHYLAXIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; INFANT; METHODOLOGY; MULTICENTER STUDY; NEWBORN; PALLIATIVE THERAPY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INFANT; INFANT, NEWBORN; LEUKEMIA, MYELOID, ACUTE; MALE; PALLIATIVE CARE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84879715590     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-01-476614     Document Type: Article

References (22)

1. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia. 2004;18(1):72-77. (Pubitemid 38159441)
2. Sung L, Lange BJ, Gerbing RB, Alonzo TA, Feusner J. Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood. 2007;110(10):3532-3539. (Pubitemid 350159617)
3. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med. 2005;142(12 Pt 1):979-995. (Pubitemid 40840313)
4. Sung L, Nathan PC, Alibhai SM, Tomlinson GA, Beyene J. Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med. 2007;147(6):400-411. (Pubitemid 351664541)
5. Sung L, Phillips R, Lehrnbecher T. Time for paediatric febrile neutropenia guidelines - children are not little adults. Eur J Cancer. 2011;47(6):811-813.
6. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol. 1997;99(3):580-588.
7. Mack MJ. Clinical trials versus registries in coronary revascularization: which are more relevant? Curr Opin Cardiol. 2007;22(6):524-528. (Pubitemid 47537937)
8. Siderowf AD. Evidence from clinical trials: can we do better? NeuroRx. 2004;1(3):363-371. (Pubitemid 46591888)
9. Sung L, Alonzo TA, Gerbing RB, et al. High mortality in extreme hyperleukocytosis in pediatric acute myeloid leukemia: a report from the Children's Oncology Group. In: Proceedings from the American Society of Hematology; December 4, 2010; Orlando, FL. Abstract 1072.
10. Gibson BE, Webb DK, Howman AJ, De Graaf SS, Harrison CJ, Wheatley K. Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial. Br J Haematol. 2011;155(3):366-376.
11. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109(1):45-60. (Pubitemid 34049426)
12. Lehrnbecher T, Ethier MC, Zaoutis T, et al. International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia. Br J Haematol. 2009;147(1):125-128.
13. Gamis AS, Howells WB, DeSwarte-Wallace J, Feusner JH, Buckley JD, Woods WG. Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891. J Clin Oncol. 2000;18(9):1845-1855. (Pubitemid 30261922)
14. Gassas A, Grant R, Richardson S, et al. Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients. J Clin Oncol. 2004;22(7):1222-1227. (Pubitemid 41079835)
15. Alexander N, Lane S, Hitchcock R. What is the evidence for radical surgery in the management of localized embryonal bladder/prostate rhabdomyosarcoma? Pediatr Blood Cancer. 2012;58(6):833-835.
16. Ehlers S, Herbst C, Zimmermann M, et al. Granulocyte colony-stimulating factor (G-CSF) treatment of childhood acute myeloid leukemias that overexpress the differentiation-defective G-CSF receptor isoform IV is associated with a higher incidence of relapse. J Clin Oncol. 2010;28(15):2591-2597.
17. Gurion R, Belnik-Plitman Y, Gafter-Gvili A, et al. Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia. Cochrane Database Syst Rev. 2012;6:CD008238.
18. Lehrnbecher T, Zimmermann M, Reinhardt D, Dworzak M, Stary J, Creutzig U. Prophylactic human granulocyte colony-stimulating factor after induction therapy in pediatric acute myeloid leukemia. Blood. 2007;109(3):936-943. (Pubitemid 46220636)
19. Ethier MC, Science M, Beyene J, Briel M, Lehrnbecher T, Sung L. Mould-active compared with fluconazole prophylaxis to prevent invasive fungal diseases in cancer patients receiving chemotherapy or haematopoietic stem-cell transplantation: a systematic review and meta-analysis of randomised controlled trials. Br J Cancer. 2012;106(10):1626-1637.
20. Robenshtok E, Gafter-Gvili A, Goldberg E, et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol. 2007;25(34):5471-5489. (Pubitemid 350232225)
21. Palmore TN, Sohn S, Malak SF, Eagan J, Sepkowitz KA. Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital. Infect Control Hosp Epidemiol. 2005;26(8):680-684. (Pubitemid 41169736)
22. Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120(16):3187- 3205.